Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Healthcare
Biotechnology
2.00 $
-3.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Cadrenal Therapeutics, Inc. Common Stock (CVKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1.2 | -3.5 | -7.4 | -13 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.0 | 0.7 | 1.4 | 1.9 | |
| 5.3 | – | – | – | |
| 0.6 | 0.1 | 1.9 | -1.3 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 0.0 | -0.3 | |
| 1.3 | -0.3 | 0.0 | – | |
| 1.2 | 12 | 9.0 | 6.6 | |
| 0.0 | 8.4 | 1.6 | -6.0 | |
| -1.2 | -3.5 | -7.4 | -13 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.